je.st
news
Tag: presented
Studies Presented at 2015 ASCO Meeting Demonstrate Predictive Power...
2015-05-30 15:37:39| Logistics - Topix.net
The meeting runs May 29-June 2, 2015, in Chicago. In the first prospective trial investigating the impact of BCI in clinical practice, BCI results led to changes in treatment decisions in 27 percent of patients tested, and significantly reduced patient anxiety regarding decisions about whether to extend endocrine therapy to 10 years.
Tags: power
presented
studies
meeting
First Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with Mercks KEYTRUDA (pembrolizumab) Presented at 2015 ASCO Annual Meeting and Published in the New England Journal of Medicine
2015-05-29 20:05:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Early Findings Show DNA Mismatch Repair-Deficient Colorectal and Other Tumors Highly Responsive to Checkpoint Blockade with Anti-PD-1 Therapy Merck Plans to Initiate Phase 2 Registrational Study with KEYTRUDA (KEYNOTE-164) to Evaluate MMR-Deficiency in Colorectal Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from the first study evaluating the correlation of benefit with an immunotherapy based on DNA mismatch repair (MMR) deficiency, a well-established form of genetic instability in many cancers characterized by the loss of function of the MMR pathway. Language: English Contact: MerckMedia:Pamela Eisele, 267-664-0282Claire Mulhearn, 908-200-1889orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
15/07/2015 to 15/07/2015 - BIM Workshop presented by BIFM and FutureFit
2015-05-29 16:47:14| BIFM Events
FutureFit Built Assets European project and BIFM have teamed up to host an introductory workshop about BIM in facilities management.
Tags: and
presented
workshop
bim
BIFM Workshop presented by BIFM and FutureFit
2015-05-29 16:18:00| BIFM News
FutureFit Built Assets European project and BIFM have teamed up to host an introductory workshop about BIM in the facilities management profession.
Tags: presented
workshop
bifm
futurefit
Positive clinical data of CytRx's aldoxorubicin to be presented at ASCO 2015
2015-05-27 21:43:05| Logistics - Topix.net
CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced an upcoming poster presentation regarding its lead drug candidate, aldoxorubicin, at the 2015 American Society of Clinical Oncology Annual Meeting, which is being held May 29 - June 2, 2015 in Chicago. "I am impressed by the excellent long-term cardiac safety profile we're seeing in patients who have undergone treatment with aldoxorubicin across several cancer types," said Sant P. Chawla, M.D., F.R.A.C.P., Principal Investigator and Director of the Sarcoma Oncology Center.
Tags: data
positive
presented
clinical
Sites : [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] next »